Health Supernova 2022 Health Supernova 2022
Get your ticket to attend. Join event to build your agenda.

Incubating Biotech Innovation

Room 104A

Fiona Mack
Johnson and Johnson, Regional Director JLABS

As Head of JLABS @ TMC, Fiona is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming, and P&L. In this role, she catalyzes and supports the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer, and health tech sectors.

Prior to joining JLABS, Fiona was Senior Director of External Innovation at Ipsen, supporting the expansion of the Rare Disease and Neuroscience portfolios. Before joining Ipsen, Fiona was a Director of External Innovation Oncology Discovery at Roche. While at Roche, she led cross-functional teams to identify and evaluate opportunities based on their scientific merit and strategic alignment with oncology/immuno-oncology early discovery and clinical development pipelines. Notable activities include the acquisition of Tensha Therapeutics, Tusk Therapeutics, and Ignyta, in addition to early discovery academic collaborations.

Fiona began her career in the industry as a Senior Research Scientist at Wyeth Oncology and eventually took on a senior leadership role when the company was acquired by Pfizer. Fiona was able to complement internal early drug discovery expertise with external innovation as a program leader for pipeline projects. She also led external collaborations to support IND-enabling studies for anti-sense therapeutics, bi-specific immunotherapies and antibody drug conjugates. 

Fiona earned her Ph.D. in Cell and Molecular Biology from the University of Pennsylvania and her undergraduate degree in Biology from Cornell University. Her innovative work has been published in high-impact journals and she also has several granted patents.

The momentum in digital health is escalating, as the world adjusts to new, lasting realities. JLABS is driving the innovation required. Ever since it debuted in 2012, this incubator division of Johnson & Johnson has championed dozens of budding biotech companies that are innovating across digital health and other areas. Today, JLABS is a global network of open innovation ecosystems.

In this keynote, Fiona Mack shares insights on how JLABS provides tools, infrastructure, and mentoring to help startups take their ideas forward. She’ll showcase exciting activities underway, such as their virtual JLABS model, and talk about crucial efforts to empower innovators to incorporate health equity into early research.